rs138604476
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_000232.5(SGCB):c.753+10_753+12delCTT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000285 in 1,612,864 control chromosomes in the GnomAD database, including 3 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00043 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00027 ( 2 hom. )
Consequence
SGCB
NM_000232.5 intron
NM_000232.5 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.978
Genes affected
SGCB (HGNC:10806): (sarcoglycan beta) This gene encodes a member of the sarcoglycan family. Sarcoglycans are transmembrane components in the dystrophin-glycoprotein complex which help stabilize the muscle fiber membranes and link the muscle cytoskeleton to the extracellular matrix. Mutations in this gene have been associated with limb-girdle muscular dystrophy.[provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 4-52027955-AAAG-A is Benign according to our data. Variant chr4-52027955-AAAG-A is described in ClinVar as [Benign]. Clinvar id is 466607.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000433 (66/152334) while in subpopulation EAS AF= 0.0123 (64/5186). AF 95% confidence interval is 0.00992. There are 1 homozygotes in gnomad4. There are 35 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SGCB | NM_000232.5 | c.753+10_753+12delCTT | intron_variant | ENST00000381431.10 | NP_000223.1 | |||
SGCB | XM_047416074.1 | c.543+10_543+12delCTT | intron_variant | XP_047272030.1 | ||||
SGCB | XM_047416075.1 | c.456+10_456+12delCTT | intron_variant | XP_047272031.1 | ||||
SGCB | XM_047416076.1 | c.456+10_456+12delCTT | intron_variant | XP_047272032.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000440 AC: 67AN: 152216Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
67
AN:
152216
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000995 AC: 250AN: 251380Hom.: 1 AF XY: 0.00102 AC XY: 138AN XY: 135874
GnomAD3 exomes
AF:
AC:
250
AN:
251380
Hom.:
AF XY:
AC XY:
138
AN XY:
135874
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000270 AC: 394AN: 1460530Hom.: 2 AF XY: 0.000277 AC XY: 201AN XY: 726666
GnomAD4 exome
AF:
AC:
394
AN:
1460530
Hom.:
AF XY:
AC XY:
201
AN XY:
726666
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000433 AC: 66AN: 152334Hom.: 1 Cov.: 33 AF XY: 0.000470 AC XY: 35AN XY: 74484
GnomAD4 genome
AF:
AC:
66
AN:
152334
Hom.:
Cov.:
33
AF XY:
AC XY:
35
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
16
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2E Benign:2
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Dec 04, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at